Company type
Limited Corporation
Established
2000
Size
Medium
Employees
99
Revenue
545 MDKK
Gross profit
197 MDKK
Operating Profit (EBIT)
134 MDKK
Profit for the Year
104 MDKK
Equity
146 MDKK
Advertising protection
The company is advertising protected. This means that the information may not be used for marketing purposes.
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!

Rank Profit for the Year

Rank in industry
2/288
"Top 10%"
Rank in Denmark
1,181/303,195
"Top 10%"

Top management Top 3

Board Top 3

Hans Carl Bøgh-Sørensen 36Chairman of board
Birgitte Bøgh-Sørensen 12Boardmember
Erik Sandberg 16Boardmember

Legal owners Top 3

100%Orifarm Generics Holding A/S

Rights certificate

Selskabet tegnes af den administrerende direktør og et bestyrelsesmedlem i forening, eller af to bestyrelsesmedlemmer i forening.

Company information based on CVR

NameOrifarm Generics A/S
Alternate namesAlternova A/S, Copyfarm A/S, Dansk Lægemiddelforsyning Dlf A/S, Dlf A/S, Pilum Pharma A/S Show more
CVR25674030
AddressEnergivej 15 Postboks 69, Lindved, 5260 Odense S
IndustryWholesale of medical and hospital goods [464620]
Webhttp://
Established15-10-2000 (20 yr)
Company typeLimited Corporation
Number of employees99 (Fin.Stmt)
Advertising protectionYes
AuditorDeloitte Statsautoriseret Revisionspartnerselskab since 13-10-2011
Financial statement period01-01 to 31-12
Company capital1,000,000 DKK
800,000 DKK (10-09-2004 - 19-06-2016)
700,000 DKK (09-12-2003 - 09-09-2004)
600,000 DKK (21-11-2002 - 08-12-2003)
500,000 DKK (15-10-2000 - 20-11-2002)
Articles of assoc. last20-06-2016

Member of industries

Purpose

Selskabets formål er at foretage salg af fortrinsvis generiske lægemidler i Danmark.

Financial Statement

 201920182017
Currency/unit000' DKK000' DKK000' DKK
Revenue
545,016
+8%
504,442
-
-
-
Gross Profit
197,046
+21%
162,693
-5%
171,953
+1%
Profit for the Year
103,855
+48%
70,055
-8%
76,351
-8%
Equity
145,680
+25%
116,825
+35%
86,770
+44%
Total Assets
330,196
+12%
295,017
+14%
259,688
+8%

Map